doi : 10.1016/S0039-6257(23)00079-6
Volume 68, Issue 4, July–August 2023, Pages A2-A4
Patrice M. Hicks, PhD MPH a, Linda Kang, BS a, Mikhayla L. Armstrong, BA b, Joseph R. Pongrac, BS a, Brian C. Stagg, MD MS c,d, Kate M. Saylor, MSI e, Paula Anne Newman-Casey, MD MSc a,f, Maria A. Woodward, MD MSc
doi : 10.1016/j.survophthal.2023.03.005
Volume 68, Issue 4, July–August 2023, Pages 567-577
In this scoping review, we examine underlying causes of loss to follow-up for chronic (glaucoma) and acute (corneal ulcers) eye conditions using the Penchansky and Thomas access to care framework. We explore barriers by World Health Organization income levels and by studying geographical location.
Jeannette Y. Stallworth, MD a, Kieran S. O’Brien, PhD a,b, Ying Han, MD,PhD a, Julius T. Oatts, MD
doi : 10.1016/j.survophthal.2023.01.010
Volume 68, Issue 4, July–August 2023, Pages 578-590
Glaucoma drainage devices (GDD) are increasingly utilized in the management of childhood glaucoma. This systematic review and meta-analysis assesses the efficacy of first-time Ahmed or Baerveldt implantation in children. PubMed, Embase, and Cochrane Library were searched for relevant English-language, peer-reviewed literature.
Mousumi Banerjee, MD, Shreya Nayak, MD, Saumya Kumar, MD, Amber Amar Bhayana, MD, Vinod Kumar, MS?
doi : 10.1016/j.survophthal.2023.03.002
Volume 68, Issue 4, July–August 2023, Pages 591-600
Eunice Linh You, MD a, Mélanie Hébert, MD MSc a,$, Tony Shicheng Jin, MD MSc b,$, Serge Bourgault, MD a, Mathieu Caissie, MD a, Eric Tourville, MD a, John Chen, MD b, José Ord??ez-Mena, MSc PhD c,†, Ali Dirani, MD MSc MPH a
doi : 10.1016/j.survophthal.2023.03.001
Volume 68, Issue 4, July–August 2023, Pages 601-614
We compare efficacy of treatments for chronic central serous chorioretinopathy (CSCR) > 3 months. Four treatment classes were considered: photodynamic therapy (PDT), subthreshold laser therapies (SLT), mineralocorticoid receptor antagonists (MRA) and antivascular endothelial growth factor (anti-VEGF) agents.
Marco Rispoli, MD 1, Gilda Cennamo, MD 2, Luca Di Antonio, MD 3, Marco Lupidi, MD, PhD 4,?, Mariacristina Parravano, MD 5, Marco Pellegrini, MD 6, Daniele Veritti, MD, PhD 7, Stela Vujosevic, MD 8,9, Maria Cristina Savastano, MD, PhD 10
doi : 10.1016/j.survophthal.2023.02.004
Volume 68, Issue 4, July–August 2023, Pages 615-627
We provide an overview of current macular imaging techniques and identify and describe biomarkers that may be of use in the routine management of macular diseases, particularly exudative age-related macular degeneration (AMD).
Fatemeh Bazvand, MD a, Zahra Mahdizad, MD a, Nader Mohammadi, MD a, Farhad Shahi, MD b, Masoud Mirghorbani, MD, MPH a,?, Hamid Riazi-Esfahani, MD a, Bobeck S. Modjtahedi, MD
doi : 10.1016/j.survophthal.2023.02.003
Volume 68, Issue 4, July–August 2023, Pages 628-640
Tamoxifen (TAM) is a selective estrogen receptor modulator that is used in the treatment of breast cancer. As there are estrogen receptors in the retina, retinal pigment epithelium, and choroid, these tissues may also be affected by TAM.
Cansu de Muijnck, MD a,b, Jacoline B. ten Brink, BSc c, Arthur A. Bergen, PhD c,d, Camiel J.F. Boon, MD, PhD b,e, Maria M. van Genderen, MD, PhD
doi : 10.1016/j.survophthal.2023.01.012
Volume 68, Issue 4, July–August 2023, Pages 641-654
Wolfram-like syndrome (WFLS) is a recently described autosomal dominant disorder with phenotypic similarities to autosomal recessive Wolfram syndrome (WS), including optic atrophy, hearing impairment, and diabetes mellitus. We summarize current literature, define the clinical characteristics, and investigate potential genotype phenotype correlations.
Sumit Randhir Singh, MD a,b, Harshit Vaidya, MD c, Enrico Borrelli, PhD d, Jay Chhablani, MD
doi : 10.1016/j.survophthal.2023.03.003
Volume 68, Issue 4, July–August 2023, Pages 655-668
Fovea centralis, located at the center of the macula, is packed with cone photoreceptors and is responsible for central visual acuity. Isolated foveal photoreceptor disruption may occur in a variety of hereditary, degenerative, traumatic, and toxic chorioretinal diseases.
Luis F. Nakayama, MD a,b,?, Lucas Z. Ribeiro, MD a, Robyn G. Dychiao c, Yuslay F. Zamora, MD a, Caio V.S. Regatieri, MD a, Leo A. Celi, MD, MS, MPH b,d,e, Paolo Silva, MD f,g, Lucia Sobrin, MD, MPH g,h, Rubens Belfort Jr., MD, PhD, MBA
doi : 10.1016/j.survophthal.2023.02.007
Volume 68, Issue 4, July–August 2023, Pages 669-677
Uveitis is a disease complex characterized by intraocular inflammation of the uvea that is an important cause of blindness and social morbidity. With the dawn of artificial intelligence (AI) and machine learning integration in health care, their application in uveitis creates an avenue to improve screening and diagnosis.
Upeka Nanayakkara, BMed, MD a, Muhammad A. Khan, BMed, MD a, Dilnoor K. Hargun, BMed a, Shobini Sivagnanam, BSc(Med) MBBS, MMed (Clin Epi), FRACP, FRCPA b,c, Chameen Samarawickrama, BSc(Med) MBBS, PhD, FRANZCO
doi : 10.1016/j.survophthal.2023.02.001
Volume 68, Issue 4, July–August 2023, Pages 678-696
Streptococcus is a diverse bacterial genus that is part of the ocular surface microbiome implicated in conjunctivitis, keratitis, endophthalmitis, dacryocystitis, and orbital cellulitis that can lead to decreased visual acuity and require surgical intervention.
Mohammad Soleimani, MD, FICO a,b,†, Pouya Mahdavi Sharif, MD a,†, Kasra Cheraqpour, MD, MPH a, Raghuram Koganti, MD b, Ahmad Masoumi, MD a, Seyed Mahbod Baharnoori, MD b, Mirataollah Salabati, MD c, Ali R. Djalilian, MD
doi : 10.1016/j.survophthal.2023.02.006
Volume 68, Issue 4, July–August 2023, Pages 697-712
Allogeneic hematopoietic stem cell transplantation is a definitive therapy for a variety of disorders. One of the complications is acute graft-versus-host disease (aGVHD), which has a high mortality rate.
Raul E. Ruiz-Lozano, MD a, Marcelo Salan-Gomez, MD a, Alejandro Rodriguez-Garcia, MD a, Manuel E. Quiroga-Garza, MD b, Eugenia M. Ramos-D?vila, MD a, Victor L. Perez, MD b, Nadim S. Azar, MD b, Jesus Merayo-Lloves, MD, PhD c, Julio C. Hernandez-Camarena, MD, PhD a, Jorge E. Valdez-Garc?a, MD, PhD
doi : 10.1016/j.survophthal.2023.02.009
Volume 68, Issue 4, July–August 2023, Pages 713-727
The cornea is a densely innervated avascular tissue showing exceptional inflammatory and immune responses. The cornea is a site of lymphangiogenic and angiogenic privilege devoid of blood and lymphatic vessels that limits the entry of inflammatory cells from the adjacent and highly immunoreactive conjunctiva.
Majid Moshirfar, MD a,b,c,?, Christian Peterson, BS d, Yasmyne C. Ronquillo, MD, MSc, JD a, Phillip C. Hoopes, MD, MS
doi : 10.1016/j.survophthal.2023.01.011
Volume 68, Issue 4, July–August 2023, Pages 728-745
Visualizing the posterior segment during vitreoretinal surgery can be difficult in eyes with concurrent corneal opacity. Temporary keratoprostheses have emerged as devices that ensure visibility of the posterior vitreous cavity while simultaneously preserving the donor corneal graft.
Shixu Li, MD 1,2, Xudai Ma, MD 1,2, Yongxin Zhang, MD 1,2, Yunhao Qu, MD 1,2, Ling Wang, MD, PhD 1,2,?, Lin Ye, MD, PhD
doi : 10.1016/j.survophthal.2023.02.005
Volume 68, Issue 4, July–August 2023, Pages 746-758
Severe corneal injury can lead to a decrease in light transmission and even blindness. Currently, corneal transplantation has been applied as the primary treatment for corneal blindness; however, the worldwide shortage of suitable corneal donor tissue means that a large proportion of patients have no access to corneal transplants.
Jos Rozema, PhD a,b,c,?, Sebastian Dankert, MD d, Rafael Iribarren, MD
doi : 10.1016/j.survophthal.2023.02.002
Volume 68, Issue 4, July–August 2023, Pages 759-783
Most eyes start with a hypermetropic refractive error at birth, but the growth rates of the ocular components, guided by visual cues, will slow in such a way that this refractive error decreases during the first 2 years of life. Once reaching its target, the eye enters a period of stable refractive error as it continues to grow by balancing the loss in corneal and lens power with the axial elongation.
Eliott S. Kim, BA a,b, Evan E. Afshin, MD b,c, Ebby Elahi, MD, MBA, FACS
doi : 10.1016/j.survophthal.2022.11.002
Volume 68, Issue 4, July–August 2023, Pages 784-793
Chalazia are localized cysts of chronic lipogranulomatous inflammation arising from the obstruction of sebaceous glands of the eyelid tarsal plate, including the Meibomian gland (deep chalazion) or Zeis gland (superficial chalazion).
Davide Romano, MD a, Dominique Bremond-Gignac, MD b,c, Miriam Barbany, MD d, Amna Rahman, MS e, Laura Mauring, MD f, Francesco Semeraro, MD a, Claus Cursiefen, MD, PhD g, Neil Lagali, PhD h, Vito Romano, MD
doi : 10.1016/j.survophthal.2022.11.001
Volume 68, Issue 4, July–August 2023, Pages 794-808
Congenital aniridia is a rare, panocular disorder with a main phenotypic characteristic of a partial or complete absence of the iris existing alongside other ocular morbidities such as cataract, keratopathy, optic nerve and foveal hypoplasia, and nystagmus.
Francesco Pellegrini, MD a,?, Rod Foroozan, MD
doi : 10.1016/j.survophthal.2022.05.001
Volume 68, Issue 4, July–August 2023, Pages 809-814
A 77-year-old man presented with the complaint of a painless decrease in vision in both eyes for 1 year. He underwent bilateral cataract surgery without improvement. Neuro-imaging and genetic testing for mitochondrial disease was negative.
Matthew J. Miller, BA a, M. John Hicks, MD, DDS, PhD a,b,c, Rod Foroozan, MD d,?, Michael C. Brodsky, MD
doi : 10.1016/j.survophthal.2022.08.001
Volume 68, Issue 4, July–August 2023, Pages 815-820
An 8-year-old boy presented with acute visual loss in the right eye and nausea, vomiting, and diplopia. Imaging revealed a right orbital apex mass. Biopsy showed Langerhans cell histiocytosis (LCH), and the patient was diagnosed with isolated orbital LCH causing an orbital apex syndrome.
M. Tariq Bhatti, MD a,?, Aubrey L. Gilbert, MD, PhD b, George Watson, MD c, Mark Waheed, DO b, Doran Spencer, MD, PhD
doi : 10.1016/j.survophthal.2022.09.003
Volume 68, Issue 4, July–August 2023, Pages 821-829
A 43-year-old woman presented with decreased vision in the right eye associated with painful eye movements 10 days after receiving her first dose of Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine (Pfizer Inc, New York, NY). Two days later she developed painful loss of vision in the left eye.
Michael S. Vaphiades, DO a,?, Danielle Isen, DO a, Mehdi Tavakoli, MD a, Jurij R. Bilyk, MD, FACS
doi : 10.1016/j.survophthal.2022.11.005
Volume 68, Issue 4, July–August 2023, Pages 830-833
A 10-year-old boy presented with headache, fever, left-sided ptosis, and right-sided forehead soft tissue swelling. There was no recent history of trauma or infection. The patient had a large, fluctuant mass on the right side of his forehead, upgaze restriction, left-sided ptosis, and bilateral optic disk edema.
Do you want to add Medilib to your home screen?